Zynerba: 2Q Earnings Snapshot
Aug. 02, 2018
DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Thursday reported a loss of $12 million in its second quarter.
On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 89 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 77 cents per share.
Zynerba shares have decreased 49 percent since the beginning of the year. The stock has fallen 57 percent in the last 12 months.